← All newsNewswireBausch + Lomb Corporation (TSX:BLCO)August 24, 2026 at 4:30 PM EDTBausch + Lomb advances two first-in-class eye therapies on trial resultsSource:Business WireThe full release text is being published and will appear here shortly.